Qsam Biosciences, Inc. [QPWR]

Source: 

Company Overview

Qsam Biosciences, Inc. is developing next-generation nuclear medicines for the treatment of cancer and related diseases. Our initial technology is Samarium-153 DOTMP, a/k/a CycloSam, a clinical-stage bone targeting radiopharmaceutical.